phenylalanine and Malignant Carcinoid Syndrome

phenylalanine has been researched along with Malignant Carcinoid Syndrome in 48 studies

Research

Studies (48)

Timeframe	Studies, this research(%)	All Research%
pre-1990	18 (37.50)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	23 (47.92)	24.3611
2020's	7 (14.58)	2.80

Authors

Authors	Studies
Clement, D; Houchard, A; Keeber, L; Kulke, M; Pavel, M; Srirajaskanthan, R; Weickert, MO	1
Benson, AB; Dharba, S; Joish, VN; Lapuerta, P; Sapre, D; Strosberg, J	1
Anthony, LB; Banks, P; Bergsland, E; Dillon, JS; Hörsch, D; Kulke, MH; Kunz, PL; Lapuerta, P; McKee, C; O'Dorisio, TM; Pavel, M; Warner, RRP; Welin, S	1
Calzo, FL; Colao, A; Faggiano, A; Fanciulli, G; Grossrubatscher, E; Isidori, A; Ruggeri, RM; Wood, TD	1
Feuilly, M; Fust, K; Kohli, M; Marteau, F; Maschio, M; Myrenfors, P; Pritchard, DM; Singh, S	1
Hota, S; Srirajaskanthan, R	1
Anthony, L; Banks, P; Benavent, M; Bergsland, E; Binder, P; Caplin, M; Gross, DJ; Hörsch, D; Kassler-Taub, KB; Kulke, MH; Lapuerta, P; Öberg, K; Pavel, M; Valle, JW; Welin, S	1
Markham, A	1
Kulke, MH	1
Frech, F; Joish, VN; Lapuerta, P	2
Masab, M; Saif, MW	1
Anthony, L; Arnold, K; Bergsland, E; Caplin, M; DiBenedetti, DB; Ervin, C; Evans, E; Hörsch, D; Jackson, S; Kulke, MH; Kunz, P; Lapuerta, P; Law, L; Metz, DC; Öberg, K; Pasieka, J; Pavel, M; Pavlakis, N; Ramage, J; Yang, QM	1
Kasi, PM	2
Anthony, LB; Benavent, M; Fleming, D; Fleming, R; Garcia-Carbonero, R; Gross, DJ; Hörsch, D; Jiang, W; Kassler-Taub, K; Kulke, MH; Kunz, PL; Lapuerta, P; Pavel, M; Perros, P; Srirajaskanthan, R; Warner, RRP; Wason, S; Weickert, MO	1
Chandrasekharan, C; Dillon, JS	1
Anthony, LB; Bergsland, E; Caplin, ME; Grande, E; Hörsch, D; Kaltsas, G; Kittur, A; Kulke, MH; Kunz, PL; Lapuerta, P; Lombard-Bohas, C; Öberg, K; Pavel, M; Ramage, JK; Valle, JW; Weickert, MO; Welin, S; Yang, QM	1
Lyseng-Williamson, KA	1
Jiang, W; Lapuerta, P; Perez-Olle, R	1
Beaumont, JL; Cella, D; Feuilly, M; Hörsch, D; Houchard, A; Hudgens, S; Kulke, MH; Lapuerta, P; Marteau, F; Pavel, M; Ramage, J	1
Anthony, LB; Bergsland, E; Caplin, ME; Dillon, JS; Hörsch, D; Jiang, W; Kassler-Taub, K; Kulke, MH; Lapuerta, P; O'Dorisio, TM; Öberg, K; Pavel, M; Warner, RRP	1
Benson Iii, AB; Wolin, EM	1
Benson, AB; Dharba, S; Fish-Steagall, A; Giacalone, S; Joish, VN; Kapoor, K; Lapuerta, P; Perez-Olle, R; Strosberg, J	1
Banks, P; Bergsland, E; Fleming, D; Frazier, K; Freiman, J; Jackson, J; Kulke, MH; Kvols, L; Lapuerta, P; Law, L; O'Dorisio, T; Phan, A; Sands, A; Yao, JC; Zambrowicz, B	1
Banks, P; Caplin, M; Fleming, D; Hörsch, D; Lapuerta, P; Pavel, M; Ramage, J; Sands, A; Seufferlein, T; Valle, J; Wiedenmann, B; Zambrowicz, B	1
Auguste, P; Boehm, KA; Gelhorn, HL; Jackson, J; Jackson, S; Kostelec, J; Kulke, MH; Lapuerta, P; Law, L; O'Dorisio, T; Yang, QM	1
Barriuso, J; Hubner, RA; Lamarca, A; McNamara, MG; Valle, JW	1
Anthony, LB; Banks, P; Bergsland, E; Caplin, ME; Fleming, D; Grande, E; Hörsch, D; Jackson, S; Kulke, MH; Kunz, PL; Lapuerta, P; Lombard-Bohas, C; Öberg, K; Pavel, M; Sands, AT; Valle, JW; Warner, RR; Welin, S; Zambrowicz, B	1
COLLINI, FJ	1
Engelman, K; Lovenberg, W; Sjoerdsma, A	1
Wernze, H	1
von Studnitz, W; Waldenström, J	2
Grassi, M; Grossi, F	1
Grahame-Smith, DG	1
Bianchine, JR; Satterlee, WG; Serpick, A	1
Marcussen, H	1
Shani, M; Sheba, C	1
Levine, RJ; Vaidya, AB	1
Nahum, LH	1
Sjoerdsma, A	1
Grover, V; Kazi, MU	1
Cooksey, B; Loncin, M; O'Reilly, S	1
Cooksey, B; O'Reilly, S	1

Reviews

8 review(s) available for phenylalanine and Malignant Carcinoid Syndrome

Article	Year
Serotonin pathway in carcinoid syndrome: Clinical, diagnostic, prognostic and therapeutic implications. Reviews in endocrine & metabolic disorders, 2020, Volume: 21, Issue:4 Topics: Humans; Malignant Carcinoid Syndrome; Phenylalanine; Pyrimidines; Serotonin; Signal Transduction; Tryptophan Hydroxylase	2020
Telotristat ethyl: proof of principle and the first oral agent in the management of well-differentiated metastatic neuroendocrine tumor and carcinoid syndrome diarrhea. Cancer chemotherapy and pharmacology, 2017, Volume: 80, Issue:6 Topics: Administration, Oral; Diarrhea; Female; Humans; Male; Malignant Carcinoid Syndrome; Neuroendocrine Tumors; Phenylalanine; Pyrimidines	2017
Telotristat Ethyl: A Review in Carcinoid Syndrome Diarrhoea. Drugs, 2018, Volume: 78, Issue:9 Topics: Diarrhea; Drug Interactions; Drug Therapy, Combination; Humans; Malignant Carcinoid Syndrome; Phenylalanine; Pyrimidines; Randomized Controlled Trials as Topic; Signal Transduction; Somatostatin; Treatment Outcome; Tryptophan Hydroxylase	2018
Telotristat ethyl for the treatment of carcinoid syndrome diarrhea not controlled by somatostatin analogues. Drugs of today (Barcelona, Spain : 1998), 2018, Volume: 54, Issue:7 Topics: Clinical Trials as Topic; Diarrhea; Humans; Malignant Carcinoid Syndrome; Neuroendocrine Tumors; Phenylalanine; Pyrimidines; Somatostatin	2018
Systemic Treatment Options for Carcinoid Syndrome: A Systematic Review. Oncology, 2019, Volume: 96, Issue:6 Topics: Antineoplastic Agents; Clinical Trials as Topic; Female; Humans; Male; Malignant Carcinoid Syndrome; Neuroendocrine Tumors; Phenylalanine; Practice Guidelines as Topic; Prospective Studies; Pyrimidines; Quality of Life; Somatostatin; Treatment Outcome	2019
Telotristat ethyl: a new option for the management of carcinoid syndrome. Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:18 Topics: Animals; Carcinoid Tumor; Clinical Trials as Topic; Humans; Malignant Carcinoid Syndrome; Neuroendocrine Tumors; Phenylalanine; Pyrimidines; Somatostatin; Tryptophan Hydroxylase	2016
Pharmacology of the carcinoid syndrome. Lancet (London, England), 1968, Feb-24, Volume: 1, Issue:7539 Topics: 5-Hydroxytryptophan; Bradykinin; Diarrhea; Drug Synergism; Humans; Kinins; Malignant Carcinoid Syndrome; Methysergide; Neurologic Manifestations; Phenylalanine; Prostaglandins; Serotonin; Serotonin Antagonists; Skin Manifestations	1968
Progress report: the carcinoid syndrome. Gut, 1970, Volume: 11, Issue:2 Topics: 5-Hydroxytryptophan; Antineoplastic Agents; Bradykinin; Diarrhea; Heart Valve Diseases; Humans; Hydroxyindoleacetic Acid; Kallikreins; Liver Neoplasms; Malignant Carcinoid Syndrome; Methyldopa; Methysergide; Neoplasm Metastasis; Phenoxybenzamine; Phenylalanine; Serotonin	1970

Trials

12 trial(s) available for phenylalanine and Malignant Carcinoid Syndrome

Article	Year
Weight Maintenance up to 48 Weeks in Patients With Carcinoid Syndrome Treated With Telotristat Ethyl: Pooled Data From the Open-Label Extensions of the Phase III Clinical Trials TELESTAR and TELECAST. Clinical therapeutics, 2021, Volume: 43, Issue:10 Topics: Body Weight Maintenance; Humans; Malignant Carcinoid Syndrome; Phenylalanine; Pyrimidines; Quality of Life; Treatment Outcome; Weight Loss	2021
Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Phase III Studies in Carcinoid Syndrome. Journal of gastrointestinal cancer, 2021, Volume: 52, Issue:1 Topics: Adult; Clinical Trials, Phase III as Topic; Defecation; Double-Blind Method; Female; Gastrointestinal Motility; Humans; Male; Malignant Carcinoid Syndrome; Middle Aged; Phenylalanine; Placebos; Pyrimidines; Severity of Illness Index; Time Factors; Treatment Outcome	2021
Understanding the Patient Experience with Carcinoid Syndrome: Exit Interviews from a Randomized, Placebo-controlled Study of Telotristat Ethyl. Clinical therapeutics, 2017, Volume: 39, Issue:11 Topics: Diarrhea; Double-Blind Method; Female; Humans; Male; Malignant Carcinoid Syndrome; Middle Aged; Phenylalanine; Pyrimidines; Treatment Outcome	2017
Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial. Endocrine-related cancer, 2018, Volume: 25, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Diarrhea; Double-Blind Method; Female; Humans; Hydroxyindoleacetic Acid; Male; Malignant Carcinoid Syndrome; Middle Aged; Phenylalanine; Pyrimidines; Somatostatin; Treatment Outcome	2018
Changes in Weight Associated With Telotristat Ethyl in the Treatment of Carcinoid Syndrome. Clinical therapeutics, 2018, Volume: 40, Issue:6 Topics: Aged; Body Weight; Diarrhea; Double-Blind Method; Female; Humans; Male; Malignant Carcinoid Syndrome; Middle Aged; Phenylalanine; Pyrimidines; Treatment Outcome; Tryptophan Hydroxylase	2018
Relationship Between Symptoms and Health-related Quality-of-life Benefits in Patients With Carcinoid Syndrome: Post Hoc Analyses From TELESTAR. Clinical therapeutics, 2018, Volume: 40, Issue:12 Topics: Aged; Diarrhea; Double-Blind Method; Female; Humans; Male; Malignant Carcinoid Syndrome; Neuroendocrine Tumors; Phenylalanine; Pyrimidines; Quality of Life; Treatment Outcome; Tryptophan Hydroxylase	2018
TELEPRO: Patient-Reported Carcinoid Syndrome Symptom Improvement Following Initiation of Telotristat Ethyl in the Real World. The oncologist, 2019, Volume: 24, Issue:11 Topics: Aged; Cohort Studies; Diarrhea; Female; Follow-Up Studies; Humans; International Agencies; Male; Malignant Carcinoid Syndrome; Patient Reported Outcome Measures; Phenylalanine; Prognosis; Pyrimidines	2019
Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide. Endocrine-related cancer, 2014, Volume: 21, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Diarrhea; Female; Gastrointestinal Agents; Humans; Hydroxyindoleacetic Acid; Male; Malignant Carcinoid Syndrome; Middle Aged; Octreotide; Phenylalanine; Pyrimidines; Serotonin Antagonists; Treatment Outcome	2014
Telotristat etiprate for carcinoid syndrome: a single-arm, multicenter trial. The Journal of clinical endocrinology and metabolism, 2015, Volume: 100, Issue:4 Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Female; Flushing; Gastrointestinal Transit; Humans; Hydroxyindoleacetic Acid; Male; Malignant Carcinoid Syndrome; Middle Aged; Phenylalanine; Pyrimidines; Treatment Outcome	2015
Patient-reported Symptom Experiences in Patients With Carcinoid Syndrome After Participation in a Study of Telotristat Etiprate: A Qualitative Interview Approach. Clinical therapeutics, 2016, Volume: 38, Issue:4 Topics: Aged; Antineoplastic Agents; Diarrhea; Female; Humans; Interviews as Topic; Male; Malignant Carcinoid Syndrome; Middle Aged; Phenylalanine; Pyrimidines; Treatment Outcome	2016
Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, Volume: 35, Issue:1 Topics: Aged; Antineoplastic Agents, Hormonal; Defecation; Diarrhea; Double-Blind Method; Female; gamma-Glutamyltransferase; Gastrointestinal Agents; Humans; Hydroxyindoleacetic Acid; Male; Malignant Carcinoid Syndrome; Middle Aged; Nausea; Octreotide; Peptides, Cyclic; Phenylalanine; Pyrimidines; Somatostatin; Tryptophan Hydroxylase	2017
Inhibition of serotonin synthesis by para-chlorophenylalanine in patients with the carcinoid syndrome. The New England journal of medicine, 1967, Nov-23, Volume: 277, Issue:21 Topics: Adult; Aged; Amino Acids; Female; Humans; Hydroxyindoleacetic Acid; Ileum; Indoles; Male; Malignant Carcinoid Syndrome; Middle Aged; Phenylalanine; Placebos; Serotonin; Serotonin Antagonists; Tyrosine	1967

Other Studies

28 other study(ies) available for phenylalanine and Malignant Carcinoid Syndrome

Article	Year
Clinical Benefits of Telotristat Ethyl in Patients With Neuroendocrine Tumors and Low Bowel Movement Frequency: An Observational Patient-Reported Outcomes Study. Pancreas, 2020, Volume: 49, Issue:3 Topics: Abdominal Pain; Adolescent; Adult; Aged; Child; Child, Preschool; Defecation; Diarrhea; Female; Flushing; Humans; Infant; Infant, Newborn; Male; Malignant Carcinoid Syndrome; Middle Aged; Nausea; Patient Reported Outcome Measures; Phenylalanine; Pyrimidines; Recovery of Function; Time Factors; Treatment Outcome; Young Adult	2020
A Budget Impact Model of the Addition of Telotristat Ethyl Treatment to the Standard of Care in Patients with Uncontrolled Carcinoid Syndrome. PharmacoEconomics, 2020, Volume: 38, Issue:6 Topics: Budgets; Clinical Trials, Phase III as Topic; Double-Blind Method; Drug Therapy, Combination; Humans; Malignant Carcinoid Syndrome; Markov Chains; Middle Aged; Models, Economic; Phenylalanine; Pyrimidines; Quality of Life; Randomized Controlled Trials as Topic; Somatostatin; Standard of Care; Sweden	2020
Regarding "TELEPRO: Patient-Reported Carcinoid Syndrome Symptom Improvement Following Initiation of Telotristat Ethyl in the Real World". The oncologist, 2020, Volume: 25, Issue:7 Topics: Humans; Malignant Carcinoid Syndrome; Patient Reported Outcome Measures; Phenylalanine; Pyrimidines	2020
Long-Term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms: Results from the TELEPATH Study. Neuroendocrinology, 2022, Volume: 112, Issue:3 Topics: Adult; Humans; Malignant Carcinoid Syndrome; Phenylalanine; Pyrimidines; Quality of Life; Treatment Outcome	2022
Telotristat Ethyl: First Global Approval. Drugs, 2017, Volume: 77, Issue:7 Topics: Animals; Diarrhea; Drug Approval; Drug Therapy, Combination; Humans; Malignant Carcinoid Syndrome; Neuroendocrine Tumors; Phenylalanine; Pyrimidines; Randomized Controlled Trials as Topic; Somatostatin; Tryptophan Hydroxylase; United States; United States Food and Drug Administration	2017
Advances in the management of patients with carcinoid syndrome. Clinical advances in hematology & oncology : H&O, 2017, Volume: 15, Issue:4 Topics: Carcinoid Tumor; Clinical Trials, Phase III as Topic; Diarrhea; Humans; Malignant Carcinoid Syndrome; Phenylalanine; Pyrimidines	2017
Telotristat ethyl (Xermelo) for carcinoid syndrome diarrhea. The Medical letter on drugs and therapeutics, 2017, 07-17, Volume: 59, Issue:1525 Topics: Antidiarrheals; Diarrhea; Drug Therapy, Combination; Humans; Malignant Carcinoid Syndrome; Octreotide; Phenylalanine; Pyrimidines; Treatment Outcome	2017
Cost-effectiveness analysis of telotristat ethyl for treatment of carcinoid syndrome diarrhea inadequately controlled with somatostatin analogs. Journal of medical economics, 2018, Volume: 21, Issue:2 Topics: Adult; Aged; Cost-Benefit Analysis; Diarrhea; Drug Costs; Drug Therapy, Combination; Female; Health Resources; Humans; Male; Malignant Carcinoid Syndrome; Markov Chains; Middle Aged; Phenylalanine; Pyrimidines; Quality-Adjusted Life Years; Somatostatin; Treatment Outcome; United States	2018
Budgetary Impact of Telotristat Ethyl, a Novel Treatment for Patients with Carcinoid Syndrome Diarrhea: A US Health Plan Perspective. Clinical therapeutics, 2017, Volume: 39, Issue:12 Topics: Antidiarrheals; Budgets; Diarrhea; Health Care Costs; Humans; Insurance, Health; Malignant Carcinoid Syndrome; Models, Economic; Phenylalanine; Pyrimidines; Somatostatin; United States	2017
Telotristat Ethyl for Patients With Carcinoid Syndrome Associated With Chest Pain and Hypertension. Pancreas, 2018, Volume: 47, Issue:1 Topics: Aged; Chest Pain; Female; Humans; Hypertension; Male; Malignant Carcinoid Syndrome; Middle Aged; Phenylalanine; Pyrimidines	2018
Telotristat ethyl: a novel agent for the therapy of carcinoid syndrome diarrhea. Future oncology (London, England), 2018, Volume: 14, Issue:12 Topics: Diarrhea; Humans; Malignant Carcinoid Syndrome; Phenylalanine; Prevalence; Pyrimidines; Quality of Life; Somatostatin; Treatment Outcome; Tryptophan Hydroxylase	2018
In Reply: Telotristat Ethyl for Patients With Carcinoid Syndrome Associated With Chest Pain and Hypertension. Pancreas, 2018, Volume: 47, Issue:9 Topics: Chest Pain; Humans; Hypertension; Malignant Carcinoid Syndrome; Phenylalanine; Pyrimidines	2018
Long-Term Safety Experience with Telotristat Ethyl Across Five Clinical Studies in Patients with Carcinoid Syndrome. The oncologist, 2019, Volume: 24, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Diarrhea; Female; Humans; Male; Malignant Carcinoid Syndrome; Middle Aged; Patient Safety; Phenylalanine; Pyrimidines; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Outcome	2019
Use of alpha-methyl-dopa (alpha-methyl-3,4-dihydroxy-DL-phenylalanine) in the management of the carcinoid syndrome. The New England journal of medicine, 1961, May-11, Volume: 264 Topics: Dihydroxyphenylalanine; Disease Management; Humans; Lyases; Malignant Carcinoid Syndrome; Methyldopa; Phenylalanine	1961
[Letter: Therapy of carcinoid flush]. Medizinische Klinik, 1975, Feb-14, Volume: 70, Issue:7 Topics: Carcinoid Tumor; Humans; Hydrocarbons, Chlorinated; Hyperemia; Malignant Carcinoid Syndrome; Phenylalanine; Serotonin	1975
[Pharmacological and therapeutic studies (p-chlorphenylalanin) on carcinoid syndrome in 11 cases]. Klinische Wochenschrift, 1971, Jul-01, Volume: 49, Issue:13 Topics: 5-Hydroxytryptophan; Aged; Blood Pressure; Bradykinin; Epinephrine; Female; Fenclonine; Humans; Hydroxyindoleacetic Acid; Isoproterenol; Male; Malignant Carcinoid Syndrome; Metaraminol; Middle Aged; Mixed Function Oxygenases; Norepinephrine; Phentolamine; Phenylalanine; Serotonin; Tryptophan; Tyramine	1971
Serotonin now: clinical implications of inhibiting its synthesis with para-chlorophenylalanine. Annals of internal medicine, 1970, Volume: 73, Issue:4 Topics: Adult; Aged; Animals; Behavior; Brain Chemistry; Catechols; Cattle; Depression; Diarrhea; Dogs; Enzyme Precursors; Humans; Hydroxyindoleacetic Acid; Male; Malignant Carcinoid Syndrome; Middle Aged; Phenylalanine; Rabbits; Rats; Serotonin; Serotonin Antagonists; Sexual Behavior, Animal; Sleep, REM; Testosterone; Tryptophan; Vasomotor System	1970
[Therapy of intestinal carcinoidosis]. La Clinica terapeutica, 1969, Sep-15, Volume: 50, Issue:5 Topics: Antineoplastic Agents; Bradykinin; Carcinoid Tumor; Histamine H1 Antagonists; Humans; Intestinal Neoplasms; Malignant Carcinoid Syndrome; Methysergide; Phenylalanine; Serotonin Antagonists	1969
[Pharmacological and therapeutical (p-chlorphenylalanine) studies on the carcinoid syndrome]. Verhandlungen der Deutschen Gesellschaft fur Innere Medizin, 1971, Volume: 77 Topics: Humans; Intestinal Neoplasms; Malignant Carcinoid Syndrome; Phenylalanine	1971
The carcinoid syndrome: chronic treatment with para-chlorophenylalanine. Annals of internal medicine, 1970, Volume: 72, Issue:6 Topics: Amino Acids; Chlorine; Diarrhea; Dopamine; Heart Valve Diseases; Hepatomegaly; Humans; Hydroxyindoleacetic Acid; Male; Malignant Carcinoid Syndrome; Middle Aged; Neoplasm Metastasis; Phenylalanine	1970
[The carcinoid syndrome]. Ugeskrift for laeger, 1970, Jun-18, Volume: 132, Issue:25 Topics: Amino Acids; Chlorine; Enzyme Repression; Female; Humans; Hydroxyindoleacetic Acid; Male; Malignant Carcinoid Syndrome; Methysergide; Middle Aged; Phenylalanine; Time Factors	1970
Parachlorophenylalanine treatment in carcinoid syndrome. British medical journal, 1970, Dec-26, Volume: 4, Issue:5738 Topics: Abdominal Neoplasms; Aged; Fatigue; Female; Hallucinations; Humans; Malignant Carcinoid Syndrome; Paranoid Disorders; Phenylalanine; Sleep Initiation and Maintenance Disorders	1970
Hypothermia in a patient with carcinoid syndrome during treatment with parachlorophenylalanine. The New England journal of medicine, 1971, Feb-04, Volume: 284, Issue:5 Topics: Body Temperature Regulation; Chlorine; Diarrhea; Humans; Hypothermia; Male; Malignant Carcinoid Syndrome; Middle Aged; Phenylalanine; Serotonin	1971
The carcinoid syndrome: serotonin and mental function. Connecticut medicine, 1968, Volume: 32, Issue:4 Topics: Behavior; Brain; Humans; Malignant Carcinoid Syndrome; Phenylalanine; Serotonin Antagonists	1968
Clinical aspects of indolealkylamine metabolism. Introductory remarks. Advances in pharmacology, 1968, Volume: 6, Issue:Pt B Topics: Humans; Hydroxyindoleacetic Acid; Malignant Carcinoid Syndrome; Phenylalanine; Serotonin	1968
Carcinoid tumors and the carcinoid syndrome. Journal of the American Geriatrics Society, 1969, Volume: 17, Issue:8 Topics: Adult; Aged; Bradykinin; Carcinoid Tumor; Female; Gastrointestinal Neoplasms; Humans; Kinins; Lung Neoplasms; Male; Malignant Carcinoid Syndrome; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Norepinephrine; Phenylalanine; Serotonin; Tryptophan; Tyramine	1969
Dopamine and basal ganglia disorders. Neurology, 1965, Volume: 15, Issue:11 Topics: Adult; Basal Ganglia; Dopamine; Female; Hepatolenticular Degeneration; Humans; Hydroxyindoleacetic Acid; In Vitro Techniques; Infant, Newborn; Male; Malignant Carcinoid Syndrome; Middle Aged; Movement Disorders; Parkinson Disease; Phenylalanine; Pregnancy; Serotonin; Tryptophan; Urine	1965
The relationship between 5-hydroxyindoles and catecholamines. Neurology, 1965, Volume: 15, Issue:12 Topics: Blood-Brain Barrier; Brain Chemistry; Brain Diseases; Catecholamines; Dopamine; Female; Humans; Hydroxyindoleacetic Acid; Male; Malignant Carcinoid Syndrome; Middle Aged; Movement Disorders; Phenylalanine; Serotonin; Tryptophan; Urine	1965